Question:
Is there any scientific literature that describes how the vaccines suppress innate immunity? There are many who think that the vaccine is an additional protection and does not interfere with innate antibodies. They would say that innate immunity + vaccine = super immunity. Why is this a mistake?
Answer:
Much information can be found on my website. Basically, antigen-specific Abs (e.g., vaccinal Abs) have higher affinity for the virus than innate immune Abs (see references from literature on my website re: innate / natural Abs - Topic 1).
The issues with these vaccines are extensively described on my website too and others have highlighted the issues with side effects.
As far as suppression of relevant innate immune Abs by vaccinal Abs is concerned, this has been explained more in detail in my article The alleged ‘case’ for experimental C-19 vaccination of children is merely based on silo mentality and immunological ignorance.
Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.
Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.
Email: info@voiceforscienceandsolidarity.org
.svg){kind=small}
